We're all in early. And the skepticism is why we get in cheap. I think a LOT of buyers will come in after the audit is published - including institutions.
These guys (VLVT) will stumble and fumble their way to success. I think that's how it happens - there's no one 'success' switch that gets flipped to the 'on' position overnight.
I suspect that when OTCLive can't answer a question it's because they don't know the answer and haven't gotten an answer from Matin. These guys need time to build working relationships. Some will come and go also - maybe OTCLive won't be involved forever.
A lot of new personalities have been thrust together virtually overnight with Matin: Burnetti, Lewis, Fridel, OTCLive folks, CFO, and more we're not aware of yet. Things aren't going to come off smoothly. I believe Dagynish made this point the other day also.
I'm not trying to make excuses for these guys (nor cajole anyone into buying) because I get as frustrated as anyone, but just pointing out that's why we get to buy this in the $0.03 range.